Search Within

Frieda Toomasi

Formats
  1. Journal Article (4)
  2. Conference Paper (2)
  3. Meeting Abstract (1)
Groups
  1. Department of Medicine (7)
  2. Nursing (7)
  3. Solid Tumor Oncology Division (6)
  4. Survivorship Research (5)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  6. Behavioral Sciences Service (4)

More Groups

People
  1. Andrew Seidman (4)
  2. Antonella Surbone (4)
  3. Bonnie Reichman (4)
  4. Clifford Hudis (4)
  5. David Lebwohl (4)
  6. John Crown (4)

More People

Years
  1. 2002 (1)
  2. 1993 (6)
Publications
  1. Journal of Clinical Oncology (2)
  2. Annals of the New York Academy of Sciences (1)
  3. Blood (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Journal of the National Cancer Institute - Monographs (1)
  6. Seminars in Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Oxford University Press (2)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)
  5. John Wiley & Sons (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intravenous busulfan and melphalan followed by an unmodified related or unrelated hematopoietic stem cell transplant for the treatment of advanced hematologic malignancies
    Meeting Abstract

    Papadopoulos, E. B.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A. A.; Kernan, N. A.; Perales, M. A.; Prasad, V.; Young, J. W.; Van Den Brink, M.; Toomasi, F.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
    Journal Article

    Reichman, B. S.; Seidman, A. D.; Crown, J. P. A.; Heelan, R.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Surbone, A.; Currie, V.; Hudis, C. A.; more...
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Preliminary experience with paclitaxel (TAXOL®) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer
    Conference Paper

    Seidman, A. D.; Norton, L.; Reichman, B. S.; Crown, J. P. A.; Yao, T. J.; Heelan, R.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Surbone, A.; more...
    Elsevier Inc. (1993)

    Fulltext@MSK | Save
  • Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: A preliminary report
    Journal Article

    Seidman, A. D.; Reichman, B. S.; Crown, J. P.; Yao, T. J.; Heelan, R.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Surbone, A.; Currie, V.; more...
    Journal of the National Cancer Institute - Monographs (1993)

    Fulltext@MSK | Save
  • Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor
    Journal Article

    Saltz, L.; Sirott, M.; Young, C.; Tong, W.; Niedzwiecki, D.; Tzy-Jyun, Y.; Tao, Y.; Trochanowski, B.; Wright, P.; Barbosa, K.; more...
    JNCI: Journal of the National Cancer Institute (1993)

    Fulltext@MSK | Save
  • Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer
    Journal Article

    Atiq, O. T.; Kelsen, D. P.; Shiu, M. H.; Saltz, L.; Tong, W.; Niedzwiecki, D.; Trochanowski, B.; Lin, S.; Toomasi, F.; Brennan, M.
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Taxol and recombinant human granulocyte colony‐stimulating factor, an active regimen as initial therapy for metastatic breast cancer: A preliminary report
    Conference Paper

    Reichman, B. S.; Seidman, A. D.; Crown, J. P. A.; Heelan, R.; Yao, T. J.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Surbone, A.; Currie, V.; more...
    John Wiley & Sons (1993)

    Fulltext@MSK | Save